Gyre Therapeutics (GYRE) Interest Coverage Ratio (QoQ) (2010 - 2020)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Interest Coverage Ratio (QoQ) (2010 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 88.46% |
| Dec 31, 2015 | -7,784.45% |
| Sep 30, 2015 | 95.22% |
| Dec 31, 2014 | -82.95% |
| Sep 30, 2014 | 11.06% |
| Jun 30, 2014 | -77.94% |
| Mar 31, 2014 | 84.45% |
| Dec 31, 2013 | -31.60% |
| Sep 30, 2013 | -13.37% |
| Jun 30, 2013 | -72.49% |
| Mar 31, 2013 | 42.75% |
| Dec 31, 2012 | -123.10% |
| Sep 30, 2012 | -162.58% |
| Jun 30, 2012 | 747.03% |
| Mar 31, 2012 | 124.85% |
| Dec 31, 2011 | -28.49% |
| Sep 30, 2011 | -169.87% |
| Jun 30, 2011 | -122.34% |
| Mar 31, 2011 | 1,240.51% |
| Dec 31, 2010 | -148.95% |